Inotiv Inc. Files DEF 14A for FY2025
Ticker: NOTV · Form: DEF 14A · Filed: Jan 23, 2025 · CIK: 720154
Sentiment: neutral
Topics: proxy-statement, corporate-governance, executive-compensation
TL;DR
Inotiv's DEF 14A is in, shareholders get the scoop on exec pay & board stuff. #governance
AI Summary
Inotiv, Inc. filed a DEF 14A on January 23, 2025, for the fiscal year ending September 30, 2025. The filing details executive compensation and corporate governance matters. Key individuals mentioned include Robert W. Leasure Jr., Beth A. Taylor, and John E. Sagartz, all serving as members. The company previously operated as BIOANALYTICAL SYSTEMS INC before changing its name on September 18, 1997.
Why It Matters
This filing provides crucial information for shareholders regarding executive compensation, director nominations, and other governance issues, impacting investor confidence and company strategy.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine but can reveal significant information about executive compensation and corporate governance that may impact stock price.
Key Numbers
- 20250313 — Conformed Period of Report (Fiscal year end for reporting)
- 20250123 — Filing Date (Date the DEF 14A was filed)
- 0930 — Fiscal Year End (Company's fiscal year end date)
Key Players & Entities
- Inotiv, Inc. (company) — Filer
- Robert W. Leasure Jr. (person) — Member
- Beth A. Taylor (person) — Member
- John E. Sagartz (person) — Member
- BIOANALYTICAL SYSTEMS INC (company) — Former Company Name
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit proxies from shareholders for an upcoming annual or special meeting. It provides detailed information on matters to be voted on, including director elections, executive compensation, and other corporate actions.
Who are the key individuals mentioned in the filing as members?
The filing mentions Robert W. Leasure Jr., Beth A. Taylor, and John E. Sagartz as members.
When did Inotiv, Inc. change its name from BIOANALYTICAL SYSTEMS INC?
Inotiv, Inc. changed its name from BIOANALYTICAL SYSTEMS INC on September 18, 1997.
What is the company's SIC code and industry classification?
The company's Standard Industrial Classification (SIC) code is 8731, which falls under SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH.
What is the reported fiscal year end for Inotiv, Inc. in this filing?
The conformed period of report is 20250313, and the fiscal year end is 0930, indicating the reporting period covers the fiscal year ending September 30, 2025.
Filing Stats: 4,508 words · 18 min read · ~15 pages · Grade level 16.9 · Accepted 2025-01-22 18:24:39
Filing Documents
- notv-20250122.htm (DEF 14A) — 687KB
- notv-20250122_g1.jpg (GRAPHIC) — 577KB
- notv-20250122_g10.jpg (GRAPHIC) — 2KB
- notv-20250122_g11.jpg (GRAPHIC) — 94KB
- notv-20250122_g12.jpg (GRAPHIC) — 73KB
- notv-20250122_g2.jpg (GRAPHIC) — 9KB
- notv-20250122_g3.jpg (GRAPHIC) — 574KB
- notv-20250122_g4.jpg (GRAPHIC) — 2KB
- notv-20250122_g5.jpg (GRAPHIC) — 1KB
- notv-20250122_g6.jpg (GRAPHIC) — 2KB
- notv-20250122_g7.jpg (GRAPHIC) — 2KB
- notv-20250122_g8.jpg (GRAPHIC) — 107KB
- notv-20250122_g9.jpg (GRAPHIC) — 116KB
- 0001628280-25-002250.txt ( ) — 5017KB
- notv-20250122.xsd (EX-101.SCH) — 3KB
- notv-20250122_def.xml (EX-101.DEF) — 3KB
- notv-20250122_lab.xml (EX-101.LAB) — 4KB
- notv-20250122_pre.xml (EX-101.PRE) — 2KB
- notv-20250122_htm.xml (XML) — 121KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 33 DELINQUENT SECTION 16(a) REPORTS 33 SHAREHOLDER PROPOSALS FOR 202 6 ANNUAL MEETING 33 OTHER BUSINESS 34 APPENDIX A – INOTIV, INC. 2024 EQUITY INCENTIVE PLAN AS PROPOSED TO BE AMENDED 35 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This proxy statement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected, expressed, or implied by such forward-looking information. Risks and uncertainties that could cause or contribute to such differences include, but are not limited to, those discussed in Part I, Item 1A, "Risk Factors" included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2024, as may be updated in our subsequent Quarterly Reports on Form 10-Q. Readers of this proxy statement are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. We expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. INOTIV, INC. PROXY STATEMENT ANNUAL MEETING OF SHAREHOLDERS MARCH 13, 2025 GENERAL This proxy statement is furnished by Inotiv, Inc. ("Inotiv," the "Company," "we," "us," or "our") in connection with the solicitation by the Board of Directors of the Company of proxies to be voted at the Annual Meeting of Shareholders (the "Annual Meeting") to be held at 10:00 a.m. (ET) on Thursday, March 13, 2025, and at any adjournment thereof. The meeting will be held at the Courtyard Marriott Lafayette, 150 Fairington Avenue, Lafayette, Indiana 47905. A shareholder who properly submits a proxy may revoke it at any time before it is exercised by delivering written notice to the Secretary of